CMS selects 25 participants in AI challenge

CMS has chosen 25 participants to advance to Stage 1 of its AI Health Outcomes Challenge, an initiative aimed at developing AI-driven healthcare predictions for providers and clinicians.

The participants were selected based on criteria established by a group of technical evaluators of data science experts, healthcare data specialists and clinical care providers.

CMS launched the challenge––which comes with awards totaling $1.65 million––in March this year, and extended the application period after receiving higher than expected interest. The idea for the challenge was originally planned in 2018.

“Artificial Intelligence is a vehicle that can help drive our system to value––proven to reduce out-of-pocket costs and improve quality,” CMS Administrator Seema Verma said in a statement announcing the participants. “It holds the potential to revolutionize healthcare: imagine a doctor being able to predict health outcomes––such as a hospital admission––and to intervene before an illness strikes.”

The challenge has innovators from all sectors, according to CMS. The agency received interest from more than 300 entities who submitted proposed AI solutions. Just seven of the 25 participants will advance to Stage 2 of the challenge, where they will be awarded $60,000 each and be given more time to refine their algorithms and solutions with more CMS data.

The grand prize winner will receive $1 million, with the runner-up receiving $230,000.

The 25 participants of Stage 1 include:

  1. Accenture Federal Services
  2. Ann Arbor Algorithms Inc.
  3. Booz Allen Hamilton
  4. ClosedLoop.ai
  5. Columbia University Department of Biomedical Informatics
  6. CORMAC
  7. Deloitte Consulting LLP
  8. Geisinger
  9. Health Data Analytics Institute
  10. HealthEC, LLC
  11. Hospital of the University of Pennsylvania
  12. IBM Corporation
  13. Innovative Decisions Inc.
  14. Jefferson Health
  15. KenSci Inc.
  16. Lightbeam Health Solutions, LLC
  17. Mathematica Policy Research Inc.
  18. Mayo Clinic
  19. Mederrata
  20. Merck & Co. Inc
  21. North Carolina State University
  22. Northrop Grumman Systems Corporation
  23. Northwestern Medicine
  24. Observational Health Data Sciences and Informatics
  25. University of Virginia Health System

“The participants in our AI Challenge demonstrate that such possibilities will soon be within reach,” Verma said. “We congratulate the 25 innovators who have been selected to continue, and we look forward to seeing what else they have in store.”   

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.